Repligen | RGEN - EPS - Lucro por Ação

Preço das Ações
123.46
Mudança Diária
-2.97 -2.35%
Mensal
3.07%
Anual
0.18%
Q2 Previsão
114.76

Fiscal Calendário Atual Consenso Anterior Data
FY2026Q1 Mar/2026 0.48 0.39 0.39 May/05
FY2025Q4 Dec/2025 0.49 0.44 0.44 Feb/24
FY2025Q3 Sep/2025 0.46 0.42 0.43 Oct/28
FY2025Q2 Jun/2025 0.37 0.39 0.33 Jul/29
FY2025Q1 Mar/2025 0.39 0.35 0.28 Apr/29




Eps Alterar Data
Agilent USD 1.32 0.35 2025-12
Align Technology USD 2.58 0.71 2026-03
Bio Techne USD 0.53 0.07 2026-03
BioMarin Pharmaceutical USD 0.76 0.3 2026-03
Bristol-Myers Squibb USD 1.58 0.32 2026-03
Bruker USD 0.31 0.28 2026-03
Charles River Laboratories USD 2.06 0.33 2026-03
Danaher USD 2.06 0.17 2026-03
Dentsply International USD 0.27 0.2 2026-03
General Electric Aerospace USD 1.86 0.29 2026-03
Henry Schein USD 1.32 0.02 2026-03
Illumina USD 1.15 0.2 2026-03
IQVIA Holdings USD 2.9 0.52 2026-03
Mettler Toledo International USD 8.91 4.45 2026-03
Myriad Genetics USD -0.09 0.13 2026-03
OraSure Technologies USD -0.18 0 2025-12
Pacific Biosciences Of California USD -0.17 0.12 2025-12
Pfizer USD 0.75 0.09 2026-03
Repligen USD 0.48 0.01 2026-03
Revvity USD 1.06 0.64 2026-03
Standard Biotools USD 0.33 0.29 2026-03
Thermo Fisher Scientific USD 5.44 1.13 2026-03
Waters USD 2.7 1.83 2026-03
West Pharmaceutical Services USD 2.13 0.09 2026-03